Crohn’s disease, fatigue, and infliximab: Is there a role for cytokines in the pathogenesis of fatigue?

Por Minderhoud, Itta M, Samsom, Melvin, Oldenburg, Bas
Publicado no World J Gastroenterol (2007)

C-reactive protein levels during a relapse of Crohn’s disease are associated with the clinical course of the disease

Por Koelewijn, Chantal L, Schwartz, Matthijs P, Samsom, Melvin, Oldenburg, Bas
Publicado em 2008

Mortality After First Hospital Admission for Inflammatory Bowel Disease: A Nationwide Registry Linkage Study

Por Opstelten, Jorrit L, Vaartjes, Ilonca, Bots, Michiel L, Oldenburg, Bas
Publicado no Inflamm Bowel Dis (2019)

Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn’s colitis patients in the Netherlands

Por van Rijn, Anne F, Fockens, Paul, Siersema, Peter D, Oldenburg, Bas
Publicado em 2009

Prototype evaluation of a self-management Internet diary for patients with ulcerative colitis

Por Snoei, Lucia, van Bodegraven, Ad, Oldenburg, Bas, Stijnen, Theo, Kaptein, Ad A
Publicado em 2009

Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn’s disease: A meta-analysis

Por Binion, David G, Louis, Edouard, Oldenburg, Bas, Mulani, Parvez, Bensimon, Arielle G, Yang, Mei, Chao, Jingdong
Publicado em 2011

Low rates of adherence for tumor necrosis factor-α inhibitors in Crohn’s disease and rheumatoid arthritis: Results of a systematic review

Por Fidder, Herma H, Singendonk, Maartje MJ, van der Have, Mike, Oldenburg, Bas, van Oijen, Martijn GH
Publicado em 2013

WNT-Pathway Activation in IBD-Associated Colorectal Carcinogenesis: Potential Biomarkers for Colonic Surveillance

Por Claessen, Marian M. H., Schipper, Marguerite E. I., Oldenburg, Bas, Siersema, Peter D., Offerhaus, G. Johan A., Vleggaar, Frank P.
Publicado no Cell Oncol (2010)

Gut Microbial Diversity Is Reduced in Smokers with Crohn's Disease

Por Opstelten, Jorrit L., Plassais, Jonathan, van Mil, Saskia W. C., Achouri, Emna, Pichaud, Matthieu, Siersema, Peter D., Oldenburg, Bas, Cervino, Alessandra C. L.
Publicado no Inflamm Bowel Dis (2016)

Pharmacological Activation of the Bile Acid Nuclear Farnesoid X Receptor Is Feasible in Patients with Quiescent Crohn's Colitis

Por van Schaik, Fiona D. M., Gadaleta, Raffaella M., Schaap, Frank G., van Mil, Saskia W. C., Siersema, Peter D., Oldenburg, Bas, van Erpecum, Karel J.
Publicado em 2012

Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance

Por Mahmoud, Remi, Shah, Shailja C., Torres, Joana, Castaneda, Daniel, Glass, Jason, Elman, Jordan, Kumar, Akash, Axelrad, Jordan, Harpaz, Noam, Ullman, Thomas, Colombel, Jean-Frédéric, Oldenburg, Bas, Itzkowitz, Steven H.
Publicado no Clin Gastroenterol Hepatol (2019)

Performance of EUS-FNA for mediastinal lymphadenopathy: impact on patient management and costs in low-volume EUS centers

Por Hirdes, Meike M. C., Schwartz, Matthijs P., Tytgat, Kristien M. A. J., Schlösser, Noёl J., Sie-Go, Daisy M. D. S., Brink, Menno A., Oldenburg, Bas, Siersema, Peter D., Vleggaar, Frank P.
Publicado em 2010

No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases

Por Mahmoud, Remi, Shah, Shailja C., ten Hove, Joren R., Torres, Joana, Mooiweer, Erik, Castaneda, Daniel, Glass, Jason, Elman, Jordan, Kumar, Akash, Axelrad, Jordan, Ullman, Thomas, Colombel, Jean-Frederic, Oldenburg, Bas, Itzkowitz, Steven H.
Publicado no Gastroenterology (2018)

Off‐label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis

Por Simsek, Melek, Lissenberg‐Witte, Birgit I., van Riswijk, Milou L. M., Verschuren, Sander, Hoentjen, Frank, Oldenburg, Bas, Ponsioen, Cyriel Y., van der Woude, C. Janneke, van der Meulen, Andrea E., Pierik, Marieke, Dijkstra, Gerard, de Boer, Nanne K. H.
Publicado no Aliment Pharmacol Ther (2019)

Non-adherence to Anti-TNF Therapy is Associated with Illness Perceptions and Clinical Outcomes in Outpatients with Inflammatory Bowel Disease: Results from a Prospective Multicentr...

Por van der Have, Mike, Oldenburg, Bas, Kaptein, Ad A., Jansen, Jeroen M., Scheffer, Robert C. H., van Tuyl, Bas A., van der Meulen-de Jong, Andrea E., Pierik, Marieke, Siersema, Peter D., van Oijen, Martijn G. H., Fidder, Herma H.
Publicado no J Crohns Colitis (2016)

Corrigendum: Non-adherence to Anti-TNF Therapy is Associated with Illness Perceptions and Clinical Outcomes in Outpatients with Inflammatory Bowel Disease: Results from a Prospecti...

Por van der Have, Mike, Oldenburg, Bas, Kaptein, Ad A, Jansen, Jeroen M, Scheffer, Robert C H, van Tuyl, Bas A, van der Meulen-de Jong, Andrea E, Pierik, Marieke, Siersema, Peter D, van Oijen, Martijn G H, Fidder, Herma H
Publicado no J Crohns Colitis (2018)

Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events

Por Asscher, Vera E. R., van der Vliet, Quirine, van der Aalst, Karen, van der Aalst, Anniek, Brand, Eelco C., van der Meulen-de Jong, Andrea E., Oldenburg, Bas, Pierik, Marieke J., van Tuyl, Bas, Mahmmod, Nofel, Maljaars, P. W. Jeroen, Fidder, Herma H.
Publicado no Int J Colorectal Dis (2020)

Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease

Por Spekhorst, Lieke M, Oldenburg, Bas, van Bodegraven, Ad A, de Jong, Dirk J, Imhann, Floris, van der Meulen-de Jong, Andrea E, Pierik, Marieke J, van der Woude, Janneke C, Dijkstra, Gerard, D’Haens, Geert, Löwenberg, Mark, Weersma, Rinse K, Festen, Eleonora A M
Publicado no World J Gastroenterol (2017)

PD-1(+)CD8(+) T cells are clonally expanding effectors in human chronic inflammation

Por Petrelli, Alessandra, Mijnheer, Gerdien, van Konijnenburg, David P. Hoytema, van der Wal, Maria M., Giovannone, Barbara, Mocholi, Enric, Vazirpanah, Nadia, Broen, Jasper C., Hijnen, Dirkjan, Oldenburg, Bas, Coffer, Paul J., Vastert, Sebastian J., Prakken, Berent J., Spierings, Eric, Pandit, Aridaman, Mokry, Michal, van Wijk, Femke
Publicado no J Clin Invest (2018)

Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study

Por Biemans, Vince B C, van der Meulen - de Jong, Andrea E, van der Woude, Christine J, Löwenberg, Mark, Dijkstra, Gerard, Oldenburg, Bas, de Boer, Nanne K H, van der Marel, Sander, Bodelier, Alexander G L, Jansen, Jeroen M, Haans, Jeoffrey J L, Theeuwen, Rosaline, de Jong, Dirk, Pierik, Marie J, Hoentjen, Frank
Publicado no J Crohns Colitis (2020)